Medicines Transparency Alliance - Zambia Billy Mweetwa Country Medicines Advisor – Zambia.

Slides:



Advertisements
Similar presentations
Saul Walker Policy and Research Division, DFID Jordan 4 December, 2007 Medicines Transparency Alliance (MeTA)
Advertisements

Sub-regional Training Workshop on
Financing of OAS Activities Sources of cooperation Cooperation modalities Cooperation actors Specific Funds management models and resources mobilization.
Technical cooperation with countries Technical Cooperation for essential drugs and traditional medicines September 2005.
Bank Group Engagement in Extractive Industries (EI) Presentation by Tove STRAUSS Governance Division (OSGE.1) African Development Bank Tunis, TUNISIA.
Zambian Civil Society Organizations, TRIPS and Access to Medicines Zambia Civil Society Consultation Meeting 1 st October 2013 Daniel S. Libati, LLB (UNZA)
Presentation by Cambodian Participants Phuket, Thailand February 2012 Health Impact Assessment Royal Government of Cambodia.
First Evaluation of Good Governance for Medicines Programme Brief Summary of Findings.
Presented to CSO workshops in Kabwe on 18 July 2014, Livingstone on 28 July 2014 and Lusaka on 27 August 2014.
Medicines Transparency Alliance (MeTA) Presented to CSO workshops during 2013 in SOLWEZI AUGUST 27 NDOLA AUGUST 29 LUSAKA OCTOBER 22.
“IMPROVING FINANCIAL OVERSIGHT: ROLE OF THE PUBLIC ACCOUNTS COMMITTEE CLERK” MALAWI’S EXPERIENCE By Joseph Joel Manzi Clerk of the Public Accounts Committee.
ILLEGAL DRUG STORES IN ZAMBIA PRESENTED BY A. PHIRI ARTHUR DAVISON CHILDREN’S HOSPITAL Presented to CSO workshop in Ndola on 29 August 2013.
Financial Transparency and Accountability in Ethiopia
Medicines Transparency Alliance Presented by Deirdre Dimancesco Department of Essential Medicines and Health Products, WHO at the Technical Briefing Seminar.
National Evaluation and Results Management System– Sinergia – Two decades of lessons and experiences Directorate of Monitoring and Evaluation of Public.
Health Care Financing Strategy: Towards Universal Health Coverage Md. Ashadul Islam Director General Health Economics Unit Ministry of Health and Family.
THE NATIONAL FOREST PROGRAMME FACILITY Zambia September 2006.
Birgit Kerstens 1, Samia Saad 2, Wilbert Bannenberg 1,2 1 Health Research for Action (HERA), Belgium; 2 Medicines Transparency Alliance (MeTA) Pilot, United.
UN-Water Water Country Briefs Introduction & Background Frederik Pischke Interagency Water Advisory UN-Water Frederik Pischke Interagency Water Advisory.
MeTA Jordan Executive Summary Baseline data is an important source for policy makers to diagnose the pharmaceutical and health sector situation in order.
Medicines Transparency Alliance05/09/2015 Medicine Promotion Robert Louie P. So, MD Program Manager DOH - National Center for Pharmaceutical Access and.
Medicines Transparency Alliance07/09/ MeTA Zambia Country Overview Public Sector Private Sector Civil Society.
RH Commodity Security in Uganda: Perspectives of Parliament Ruth Kavuma Nvumetta Woman MP, Kalangala District (Ssese Islands) Member, Network of African.
Medicines Transparency Alliance13/09/ MeTA Uganda Country Overview Public Sector Private Sector Civil Society.
MULTI-STAKEHOLDER COLLABORATION: CAN IT IMPROVE TRANSPARENCY, DISCLOSURE AND ACCESS TO MEDICINES? EXPERIENCES FROM 7 META PILOT COUNTRIES Wilbert Bannenberg.
PARIS21 Secretariat (Partnership in Statistics for Development in the 21 st Century) Millicent Gay Tejada 12 June th SAARCSTAT Meeting, Kathmandu,
Wilbert Bannenberg, Technical Director MeTA International Secretariat IACC 14 Bangkok, 13 November 2010 MeTA multi-stakeholder process – a way to improve.
Wilbert Bannenberg SARPAM
Medicines Transparency Alliance01/10/2015 Availability of Medicines Anita Wagner Harvard Medical School & WHO Collaborating Center in Pharmaceutical Policy.
Data Disclosure: An Ongoing Progress Towards Transparency Abeer Rabayah B.Sc Pharmacy -MBA /Marketing MeTA National Coordinator.
Medicines Transparency Alliance03/10/ MeTA Zambia Violet Kabwe MeTA Zambia Consultant.
TB PUBLIC-PRIVATE MIX DOTS Dr. Team Bakkhim Deputy Director CENAT Intercontinental Hotel 7 th November, 2012 NATIONAL FORUM ON PUBLIC-PRIVATE PARTNERSHIP.
Contact Monitoring Regional Network (CMKN). Why procurement It is estimated that an effective public procurement system could save as much as 25% of government.
1 Towards a Medicines Transparency Alliance (MeTA) Richard Laing and Ali Cameron with slides prepared by Michael Borowitz, DfID WHO Technical Briefing.
Samia Saad 1, Birgit Kerstens 2, Wilbert Bannenberg 1,2 1 Medicines Transparency Alliance (MeTA) Pilot, United Kingdom; 2 Health Research for Action (HERA),
Governance Survey Conducted by the Palestinian Central Bureau of Statistics (PCBS) Presented to Workshop on Governance Assessments for Accountable Politics.
Harnessing a multi-stakeholder platform for improved land governance in Malawi Ivy Luhanga – Principal Secretary, Paul Jere – Land Governance Consultant,
MALAWI GOVERNMENT MINISTRY OF HEALTH PROGRESS ON GOOD GOVERNANCE IN THE PHARMACEUTICAL SECTOR IN MALAWI By Dr Charles Mwansambo Secretary for Health 20.
Africa Health Workforce Platform & Observatory Presentation to the 1st conference of the Asia-Pacific Action Alliance on HRH (AAAH): October 2006.
Medicines Transparency Alliance27/10/ MeTA Ghana Augustina Koduah (Mrs) Country Coordinator.
MeTA Medicines Transparency Alliance: Under New Management Dr Tim Reed Director, Health Action International (Global) International MeTA Secretariat.
Medicines Transparency Alliance31/10/ MeTA Zambia – Pricing Goodwell Lungu MeTA Secretary General.
Objective the aim of this project was directly addressing a major health problem for Jordan by producing a guideline as a pilot in which the strengths.
Medicines systems: Convergence for access Dr Socorro Escalante WHO Country Office for Viet Nam 1.
WHO-Technical Briefing Seminar | October-November 2012 Dr Cécile Macé 1 |1 | Good Governance for Medicines Programme Dr Cécile Macé EMP/MPC.
 Introduction  Local AIDS Governance Barometer (LAGB) Model  LAGB Purpose  LAGB Application – Kabwe district, Zambia  LAGB’s Contribution to the.
NSDS DESIGN PROCESS: ROAD MAPS & OTHER PRELIMINARIES Prof. Ben Kiregyera NSDS Workshop, Addis Ababa, Ethiopia 9 August 2005.
Medicines Transparency Alliance Presented by Gilles Forte Department of Essential Medicines and Health Products, WHO On behalf of WHO and HAI Technical.
Preparatory Stakeholder Workshop - Laos 26 May 2010.
Revisions Proposed to the CIS Plan by the Global Office Misha V. Belkindas Budapest, July 3-4, 2013.
Efficiency ׀ Transparency ׀ Accountability Multi-Donor Trust Fund Office Fund Management for Development Assistance UN-REDD Programme Policy Board Panama,
Medicines Transparency Alliance18/12/ Country overview MeTA Kyrgyzstan Mariam Djankorozova MeTA Country coordinator.
Observatories for the Health Workforce in Africa VIII REGIONAL MEETING OF THE OBSERVATORIES OF HUMAN RESOURCES FOR HEALTH IN THE AMERICAS LIMA, PERU
Medicines Transparency Alliance31/01/ MeTA Uganda Jacqueline Idusso Secretariat Coordinator.
Wilbert Bannenberg & Elodie Brandamir Technical & Operational Directors MeTA International Secretariat MeTA Kyrgyzstan Forum Bishkek, 16 April 2009 Medicines.
Wilbert Bannenberg Technical Director, Intl MeTA Secretariat 28 April 2010, IPC meeting, Copenhagen Medicines Transparency Alliance: improving people’s.
MeTA Phase I: Where are we? MeTA18/06/ MeTA2 The MeTA Phase I Proposal Purpose To pilot a new multi-stakeholder approach towards increasing transparency.
Non-Government Partnership: Lessons Learned from Indonesia The 1 st Asian Public Governance Forum on Public Innovation Jakarta, 12 June 2014 Erny Murniasih.
The Medicines Transparency Alliance Saul Walker Senior Policy Advisor, Access to Medicines Health Services Team.
EDM Strategy for Working with Countries: the Uganda Example
SADC Medicines Database (SMD)
Developing reporting system for SDG and Agenda 2063, contribution of National Statistical System, issues faced and challenges CSA Ethiopia.
Wilbert Bannenberg SARPAM
Implementing the guideline
ROLES AND RESPONSIBILITIES OF VARIOUS LEVELS IN ESTABLISHING AND IMPLEMENTING THE ADDO PROGRAM August 2009.
WHO Medicines Work in Countries: The Kenya Example
IMPROVING JSR PRACTICES AT COUNTRY LEVEL: ACHIEVEMENTS AND GAPS
Ministries Expectation of NGOs in the Health Sector
MeTA Philippines Roberto M. Pagdanganan
Stop Stock-outs Campaign in Uganda
Presentation transcript:

Medicines Transparency Alliance - Zambia Billy Mweetwa Country Medicines Advisor – Zambia

MeTA International Aim MeTA aims at improving access to quality medicines by increasing transparency of the pharmaceutical sector through collection of reliable data, valid analysis, and then disclosure for advocacy and public dialogue among stakeholders i.e. private/public sector/civil society

MeTA Hypothesis Transparency RELIABLE INFORMATON Multi- stakeholder approach Improved accountability Improved governance Improved efficiency Improved Policies Improved access to Medicines

How MeTA works WHO and Health Action International; – Project coordination – Technical support through the provision of data collection tools, methodologies, capacity building and guidance – Approvals of plans (centre), funds disbursements and monitoring implementations MeTA councils: Multi-stakeholder group that agrees to plan, discusses results MeTA Secretariat: Provides in country coordination for council WHO Country Office: Provide technical support

About MeTA Zambia Part of 7 countries project – Ghana, Jordan, Kyrgyzstan, Peru, Philippines, Uganda and Zambia It has a council in place – multi-stakeholder based – Chair from law maker background –former MP ruling party – Vice Chair MoH – Deputy Director MoH – P’ceutical Services Has conducted Phase 1 Pilot (2008 to 2010) – Was multi-stakeholder approach to establish baseline data

Areas of interest in Phase 1 Retail Pricing (Recommended Retail Price Study) Role of informal pharmacy Sector – Accreditation of informal sector pharmacy outlets done – modeled around ADDO – Accredited Drug Dispensing Outlets Private sector Mapping Study (local production)

Areas of interest in Phase 1 Capacity building Media personnel ( workshops) Advocacy on pricing – radio live phoning programs, public drama programs in selected districts Policy dialogue – involving ministry, regulator, private and Civil Society

Successes All planned activities were implemented successfully MeTA Council was functional Activities of phase one disseminated to wide group through MeTA forum One of the activities has contributed to some policy change – accredited informal pharmacy outlets – though to be yet approved

successes MoH is viewing MeTA as a partner in increasing transparency in the supply chain MoH would like MeTA to do more around price monitoring Phase I is the platform for phase II

Challenges/threats Most of the prep work for Phase II has been done by volunteers Need to publish the works done so far Heavy dependency on external funding Good governance and Transparency in Medicines relatively new concept – Sharing of information both private and public is still an issue – Accountability and efficiency need to institutionalized

MeTA Zambia Phase II Proposal submitted for approval – Plans are based on the works done in phase two – More advocacy work for the public though media program – Will play an active role in monitoring prices both for private and public sector (procurement) – Policy dialogue will be active Secretariat: – Coordinator plan to be part time

Lessons learnt Pilot phase should have all stakeholders involved MoH should feel part of the MeTA Council Having a politician in the council helped have political presence Local private sector is ready to fund some activities as long as they feel part of the process

Lessons leant The concept of MeTA is new in this sector therefore cooperation from stakeholders take time Ministry is willing to work with MeTA provided mandate is made clear Evidence can help change policies and practices Consensus building takes time and needs patience

Lessons learnt Policy dialogue takes time The work needed to be done needs committed team Capacity building is essential for MeTA council members

Acknowledgements MeTA Zambia the Executive committee currently working as volunteers, TIZ saving as the secretariat Former coordinator Violet Kabwe and her team WHO/HAI HQ for guidance DFID – Funders for the project MoH – Zambia, Private Sector, Civil Society, Media Houses Stop Stock Out Project

Twalumba (Thank You)